HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients
dc.contributor.author | Topcuoglu, P. | |
dc.contributor.author | Gulbas, Z. | |
dc.contributor.author | Savran, F. Oguz | |
dc.contributor.author | Beksac, M. | |
dc.contributor.author | Yesilipek, A. | |
dc.contributor.author | Arat, M. | |
dc.contributor.author | Atilla, E. | |
dc.contributor.author | Dalva, K. | |
dc.contributor.author | Atilla, P. Ataca | |
dc.contributor.author | Toprak, S. K. | |
dc.date.accessioned | 2021-03-03T12:00:56Z | |
dc.date.available | 2021-03-03T12:00:56Z | |
dc.identifier.citation | Atilla E., Dalva K., Atilla P. A. , Toprak S. K. , Topcuoglu P., Gulbas Z., Arat M., Yesilipek A., Savran F. O. , Beksac M., "HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients", 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_2b607972-06e6-4be8-b3f7-032c02a0203e | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/33904 | |
dc.language.iso | eng | |
dc.subject | TRANSPLANTASYON | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Biyofizik | |
dc.subject | Biyokimya | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Hematoloji | |
dc.subject | Onkoloji | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | HEMATOLOJİ | |
dc.subject | İmmünoloji | |
dc.subject | BİYOFİZİK | |
dc.subject | Biyoloji ve Biyokimya | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.title | HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 52 | |
dc.contributor.firstauthorID | 151892 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]